PATRICIA WIESER: Open Payments
NPI 1639216112 · BELMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 31 payments from 16 companies in 2025. Trend: 2023 $152 · 2024 $415 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $203 |
| Exact Sciences Corporation | 5 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $58 |
| Lilly USA, LLC | 3 | $52 |
| Viatris Specialty LLC | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Edwards Lifesciences Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Ozempic, Cologuard Collection Kit, XIFAXAN, MOUNJARO, YUPELRI, JARDIANCE, BREZTRI, SAPIEN 3 Ultra RESILIA.
Industry payments across CA — which companies pay providers there.
